Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Ardelyx Inc (ARDX)

Ardelyx Inc (ARDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Ardelyx to Participate at the 2024 Jefferies London Healthcare Conference GlobeNewswire - 1 hour ago

ARDX : 5.90 (+0.17%)
Ardelyx: Q3 Earnings Snapshot AP - Thu Oct 31, 3:22PM CDT

Ardelyx: Q3 Earnings Snapshot

ARDX : 5.90 (+0.17%)
Ardelyx Reports Third Quarter 2024 Financial Results and Provides Business Update GlobeNewswire - Thu Oct 31, 3:02PM CDT

ARDX : 5.90 (+0.17%)
Amarin's Q3 Earnings In Line, Revenues Fall Shy of Estimates
Amarin's Q3 Earnings In Line, Revenues Fall Shy of Estimates Zacks Investment Research - Thu Oct 31, 12:12PM CDT

Amarin Corporation plc AMRN reported an adjusted loss of 5 cents per share for the third quarter of 2024, which was in line with the Zacks Consensus Estimate. The company had reported breakeven earnings...

FOLD : 11.33 (-1.22%)
AMRN : 0.6194 (+2.43%)
ARDX : 5.90 (+0.17%)
ATNM : 1.7600 (+2.92%)
Corcept Trumps Q3 Earnings & Sales Estimates, Ups '24 Revenue View
Corcept Trumps Q3 Earnings & Sales Estimates, Ups '24 Revenue View Zacks Investment Research - Thu Oct 31, 12:12PM CDT

Corcept Therapeutics Incorporated CORT reported third-quarter 2024 earnings of 41 cents per share, which significantly beat the Zacks Consensus Estimate of 27 cents. The company had reported earnings of...

FOLD : 11.33 (-1.22%)
CORT : 50.32 (+0.52%)
ARDX : 5.90 (+0.17%)
ATNM : 1.7600 (+2.92%)
Ardelyx Presents Results from its IBS in America 2024 Supplemental Survey at the American College of Gastroenterology’s (ACG) Annual Meeting GlobeNewswire - Mon Oct 28, 3:05PM CDT

ARDX : 5.90 (+0.17%)
Ardelyx Shares Additional Data Supporting First-In-Class XPHOZAH® (tenapanor) at the American Society of Nephrology’s Kidney Week GlobeNewswire - Thu Oct 24, 3:05PM CDT

ARDX : 5.90 (+0.17%)
Ardelyx Announces Launch of Gut Matters: Discoveries and Innovations, a New Podcast for the IBS-C Patient Community GlobeNewswire - Tue Oct 22, 3:05PM CDT

ARDX : 5.90 (+0.17%)
Ardelyx Announces the Derek Forfang Patient Advocate Award to Recognize Advocates for the Chronic Kidney Disease Community GlobeNewswire - Mon Oct 21, 3:05PM CDT

ARDX : 5.90 (+0.17%)
Ardelyx to Report Third Quarter 2024 Financial Results on October 31, 2024 GlobeNewswire - Thu Oct 17, 7:00AM CDT

ARDX : 5.90 (+0.17%)

Barchart Exclusives

3 Cheapest Dividend Kings Primed for Big Gains in 2025 Barchart - 22 minutes ago
Discover three dividend kings that are trading at a discount. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot